- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22:18 | BridgeBio plans $550 million convertible notes offering to refinance debt | 1 | Investing.com | ||
| 22:12 | BridgeBio plans $550M convertible notes offering due 2033 | 1 | Seeking Alpha | ||
| 22:10 | Bayer taps Gabrielle Union-Wade as face of menopause med Lynkuet | 7 | FiercePharma | ||
| 22:06 | BridgeBio Pharma, Inc.: BridgeBio Continues Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027 | 1 | GlobeNewswire (USA) | ||
| 21:48 | Compounding pharmacy sues Lilly, Novo over GLP-1 drug competition | 9 | Seeking Alpha | ||
| 21:34 | TG Therapeutics: Cantor Fitzgerald bestätigt "Overweight"-Rating und sieht über 50 % Kurspotenzial | 1 | Investing.com Deutsch | ||
| 21:30 | TG Therapeutics stock holds Overweight rating at Cantor Fitzgerald | 2 | Investing.com | ||
| 21:26 | JPM26: With pricing deal in the books, Sanofi steels against lingering policy unknowns | 4 | FierceBiotech | ||
| 21:01 | Eli Lilly's Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief | 5 | The Motley Fool | ||
| 20:42 | Grail and Indivior PLC come out on top in Healthcare quant picks ahead of Q4 earnings | 1 | Seeking Alpha | ||
| 20:30 | Abend-Update: Rallye-Alarm bei Bayer: Der Markt kippt auf "Kaufen" | Hebelschein-Spekulant | |||
| 19:55 | IN BRIEF: Oxford Biomedica confirms fresh EQT takeover approach | 3 | Alliance News | ||
| 19:46 | JPM26: Bayer evades patent cliff in a way it may not be able to repeat | 84 | Pharmaceutical Technology | ||
| 19:31 | Why Eli Lilly Stock Gained 39.2% In 2025 | 7 | The Motley Fool | ||
| 19:26 | Bristol-Myers Squibb Reports Positive Phase 3 SCOUT-HCM Results for Camzyos in Adolescent Patients | 17 | Insider Monkey | ||
| 19:06 | Happy Belly Food Group Inc: Happy Belly's Heal obtains Calgary franchise location | 1 | Stockwatch | ||
| 18:46 | Lilly, chasing Novo, expects second-quarter FDA decision on obesity pill | 42 | BioPharma Dive | ||
| 18:46 | JPM26: AstraZeneca bids to accelerate oncology R&D with Modella AI acquisition | 2 | Pharmaceutical Technology | ||
| 18:43 | Bayer Expands Into Molecular Imaging With Acquisition Of Attralus Pan-Amyloid Radiotracers | 33 | pulse2.com | ||
| 18:36 | Sanofi: Information concerning the total number of voting rights and shares - December 2025 | 6 | GlobeNewswire (USA) |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| BAYER | 40 | 36 | +7,00 % | Märkte am Morgen: Siemens, Nvidia, Microchip Technology, Novo Nordisk, Adidas, Bayer | Der DAX hat in dieser Woche bisher Stärke gezeigt und den geopolitischen Ereignissen damit getrotzt. Sowohl am Montag als auch gestern erreichte er neue Bestmarken. Auch heute deuten sich Gewinne an.... ► Artikel lesen | ||
 | NOVO NORDISK | 15 | 40 | -1,33 % | Compounding pharmacy sues Lilly, Novo over GLP-1 drug competition | ||
| ELI LILLY | 12 | 125 | -0,49 % | Eli Lilly - LLY: Kursfantasie dank Medikamenten-Boom! | Starke Wachstumsprognosen! Analysten sehen weiter großes Potenzial bei Eli Lilly (LLY): Knackiges Breakout-Setup! Eli Lilly (LLY) - ISIN US5324571083 Rückblick: Während Pharma-Aktien sich über die Feiertage... ► Artikel lesen | ||
| TG THERAPEUTICS | 8 | 1 | +6,73 % | After-Hours Biotech Rally: SXTC, RPID, TGTX Lead Gains On Revenue Updates, And FDA Milestones | BEIJING (dpa-AFX) - Several biotechnology and pharmaceutical names posted notable gains in Tuesday's after-hours trading session, driven by corporate updates and investor enthusiasm around clinical... ► Artikel lesen | ||
| AVADEL PHARMACEUTICALS | 7 | 6 | -1,62 % | Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.... ► Artikel lesen | ||
| ASTRAZENECA | 6 | 22 | +2,36 % | Aktie im Plus: AstraZeneca mit Studienerfolg: Saphnelo überzeugt erneut | © Foto: Marcus Brandt/dpaAstraZeneca berichtet von einem Erfolg in einer Selbstverabreichungsstudie: Das zur Behandlung bei der Autoimmunerkrankung, systemischer Lupus erythematodes (SLE) eingesetzte... ► Artikel lesen | ||
| HUTCHMED | 6 | 7 | -1,64 % | HUTCHMED Announces Publication Of Phase III SACHI Study Results In The Lancet | LONDON (dpa-AFX) - HUTCHMED (China) Limited (HCM) on Wednesday said results from the Phase III SACHI trial evaluating savolitinib in combination with osimertinib were published in The Lancet.The... ► Artikel lesen | ||
| PFIZER | 5 | 92 | +1,71 % | mRNA Patentstreit: Bayer zieht BioNTech, Pfizer und Moderna vor Gericht | © Foto: Juan Vega - EUROPA PRESSBayer erhebt schwere Patentvorwürfe gegen die Hersteller der erfolgreichsten Corona-Impfstoffe. Im Zentrum steht eine mRNA-Technologie aus den 1980er-Jahren.Der Agrar-... ► Artikel lesen | ||
 | CHINA TRADITIONAL CHINESE MEDICINE | 5 | - | +1,77 % | TRAD CHI MED (00570): LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CIRCULAR AND NOTICE FOR THE EXTRAORDINARY GENERAL ... | ||
 | NEUREN PHARMACEUTICALS | 4 | 1 | +5,66 % | Neuren Pharma Expects DAYBUE Global Net Sales To Touch $700 Mln In FY28 |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| PFIZER INC | 21,955 | 33,90 | +54 % | 3 | 8 | - | |||
| SCHOTT PHARMA AG & CO KGAA | 15,100 | 21,15 | +40 % | 7 | 6 | - | |||
| DOCMORRIS AG | 6,485 | 8,78 | +35 % | 1 | 2 | 2 | |||
| SANOFI SA | 82,58 | 101,75 | +23 % | 21 | 8 | - | |||
| MERCK KGAA | 127,00 | 141,17 | +11 % | 16 | 3 | - | |||
| ASTRAZENECA PLC | 165,05 | 172,60 | +5 % | 16 | 1 | 5 | |||
| NOVO NORDISK A/S | 50,56 | 50,91 | +1 % | 26 | 13 | 4 | ||
| NOVARTIS AG | 125,08 | 119,33 | -5 % | 10 | 10 | 1 | |||
| ROCHE HOLDING AG GS | 370,55 | 352,75 | -5 % | 9 | 14 | 13 | |||
| DERMAPHARM HOLDING SE | 38,200 | 34 | -11 % | - | 2 | - | |||
| BAYER AG | 41,670 | 35,50 | -15 % | 9 | 17 | - | |||
| GSK PLC | 21,680 | 18,12 | -16 % | 6 | 15 | 8 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .